Who are EyePoint, Inc.'s main suppliers?

EyePoint, Inc. (EYPT) key suppliers include: THIRD-PARTY-SUPPLIER, ANI Pharmaceuticals, Inc., ANI Pharmaceuticals, Inc.. View the full supplier network at chainsifter.com/chain/EYPT.

Who are EyePoint, Inc.'s major customers?

EyePoint, Inc. (EYPT) key customers include: OCULAR-THERAPEUTIX-INC, PARTNER, ANI Pharmaceuticals, Inc., ANI Pharmaceuticals, Inc.. View the full customer network at chainsifter.com/chain/EYPT.

What sector is EyePoint, Inc. in?

EyePoint, Inc. (EYPT) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

EYPT Supply Chain: EyePoint, Inc. Supplier List & 9 Relationships

3Suppliers

4Customers

2Debt Items

6Related Chains

EyePoint, Inc. Suppliers

Ticker	Name	Confidence	Evidence
THIRD-PARTY-SUPPLIER	THIRD-PARTY-SUPPLIER	90%	We source the API from Farmabios, needles from a third party supplier and various other raw materials and components for YUTIQ ® from additional third-party vendors.
ANIP	ANI Pharmaceuticals, Inc.	72%	financial statements. It is important that the discussion of our operating results that follows be read in conjunction with the critical accounting policies discussed below. Revenue Recognition Reven…
ANIP	ANI Pharmaceuticals, Inc.	72%	Reciprocal relationship from ANIP graph: Reciprocal relationship from EYPT graph: financial statements. It is important that the discussion of our operating results that follows be read in conjunctio…

EyePoint, Inc. Customers

Ticker	Name	Confidence	Evidence
OCULAR-THERAPEUTIX-INC	OCULAR-THERAPEUTIX-INC	90%	The Complaint alleges, among other things, Defendant's dissemination of false or misleading representations of fact concerning the Company and the clinical results of the Company's lead product candi…
PARTNER	PARTNER	90%	we are supplying such product to our partner pursuant to our agreement with them.
ANIP	ANI Pharmaceuticals, Inc.	72%	financial statements. It is important that the discussion of our operating results that follows be read in conjunction with the critical accounting policies discussed below. Revenue Recognition Reven…
ANIP	ANI Pharmaceuticals, Inc.	72%	Reciprocal relationship from ANIP graph: Reciprocal relationship from EYPT graph: Reciprocal relationship from ANIP graph: Reciprocal relationship from EYPT graph: financial statements. It is importa…

EyePoint, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
EYPT-DEBT-9417	Warrants outstanding: 12.33	90%	xbrl warrant detail from xbrl 2024-12-31.
EYPT-DEBT	Debt stack $17.6M	90%	Market cache reports total debt of $17.6M.

EyePoint, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for EyePoint, Inc..

EyePoint, Inc. Ownership

Holder	Name	Confidence	Evidence
EYPT-OWNER-SUVRETTA-CAPITAL-MANAGEMENT-LLC	SUVRETTA CAPITAL MANAGEMENT, LLC	90%	13F overlay lists SUVRETTA CAPITAL MANAGEMENT, LLC as top holder; 192 tracked holders.

EyePoint, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
KLRS	Kalaris Therapeutics, Inc.	100.00	2
EMMA	Emmaus Life Sciences, Inc.	50.00	2
CELG-RI	BRISTOL MYERS SQUIBB CO	50.00	2
IRD	Opus Genetics, Inc.	50.00	2
ANIP	ANI Pharmaceuticals, Inc.	38.88	1	['customer', 'supplier']
OCUL	Ocular Therapeutix, Inc.	38.88	1	['receiving']

EyePoint, Inc. Supply Chain